Report cover image

Global Medicated Adhesive Patch Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 192 Pages
SKU # APRC20553589

Description

Summary

According to APO Research, The global Medicated Adhesive Patch market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Medicated Adhesive Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Medicated Adhesive Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Medicated Adhesive Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Medicated Adhesive Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Medicated Adhesive Patch include Johnson & Johnson, Novartis, Mylan, Pfizer, GSK, Beijing Tide Pharmaceutical, Bayer, UCB Pharma and Teva Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
In terms of production side, this report researches the Medicated Adhesive Patch production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Medicated Adhesive Patch by region (region level and country level), by company, by type and by application. from 2020 to 2025 and forecast to 2031.

This report presents an overview of global market for Medicated Adhesive Patch, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Medicated Adhesive Patch, also provides the consumption of main regions and countries. Of the upcoming market potential for Medicated Adhesive Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medicated Adhesive Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Medicated Adhesive Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Medicated Adhesive Patch sales, projected growth trends, production technology, application and end-user industry.

Medicated Adhesive Patch Segment by Company

Johnson & Johnson
Novartis
Mylan
Pfizer
GSK
Beijing Tide Pharmaceutical
Bayer
UCB Pharma
Teva Pharmaceutical
Nitto Denko
Mundipharma
Luye Pharma Group
IBSA Group
Hisamitsu Pharmaceutical
Grünenthal
Endo International
Dr Reddy’s Laboratories
Chattem
Medicated Adhesive Patch Segment by Type

Methyl Salicylate-based Patch
Nicotine Transdermal Patch
Rivastigmine Transdermal Patch
Clonidine Transdermal Patch
Fentanyl Transdermal Patch
Oxybutynin Transdermal Patch
Others
Medicated Adhesive Patch Segment by Application

Used to Treat High Blood Pressure
Used to Treat an Overactive Bladder
Used to Relieve Severe Pain
Used to Stop Smoking Cigarettes
Others
Medicated Adhesive Patch Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicated Adhesive Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medicated Adhesive Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicated Adhesive Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medicated Adhesive Patch market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medicated Adhesive Patch industry.
Chapter 3: Detailed analysis of Medicated Adhesive Patch market competition landscape. Including Medicated Adhesive Patch manufacturers' output value, output and average price from 2020 to 2025, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Medicated Adhesive Patch by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Medicated Adhesive Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Medicated Adhesive Patch Production Value Estimates and Forecasts (2020-2031)
1.2.2 Global Medicated Adhesive Patch Production Capacity Estimates and Forecasts (2020-2031)
1.2.3 Global Medicated Adhesive Patch Production Estimates and Forecasts (2020-2031)
1.2.4 Global Medicated Adhesive Patch Market Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Global Medicated Adhesive Patch Market Dynamics
2.1 Medicated Adhesive Patch Industry Trends
2.2 Medicated Adhesive Patch Industry Drivers
2.3 Medicated Adhesive Patch Industry Opportunities and Challenges
2.4 Medicated Adhesive Patch Industry Restraints
3 Medicated Adhesive Patch Market by Manufacturers
3.1 Global Medicated Adhesive Patch Production Value by Manufacturers (2020-2025)
3.2 Global Medicated Adhesive Patch Production by Manufacturers (2020-2025)
3.3 Global Medicated Adhesive Patch Average Price by Manufacturers (2020-2025)
3.4 Global Medicated Adhesive Patch Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Medicated Adhesive Patch Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Medicated Adhesive Patch Manufacturers, Product Type & Application
3.7 Global Medicated Adhesive Patch Manufacturers Established Date
3.8 Market Competitive Analysis
3.8.1 Global Medicated Adhesive Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Medicated Adhesive Patch Players Market Share by Production Value in 2024
3.8.3 2024 Medicated Adhesive Patch Tier 1, Tier 2, and Tier 3
4 Medicated Adhesive Patch Market by Type
4.1 Medicated Adhesive Patch Type Introduction
4.1.1 Methyl Salicylate-based Patch
4.1.2 Nicotine Transdermal Patch
4.1.3 Rivastigmine Transdermal Patch
4.1.4 Clonidine Transdermal Patch
4.1.5 Fentanyl Transdermal Patch
4.1.6 Oxybutynin Transdermal Patch
4.1.7 Others
4.2 Global Medicated Adhesive Patch Production by Type
4.2.1 Global Medicated Adhesive Patch Production by Type (2020 VS 2024 VS 2031)
4.2.2 Global Medicated Adhesive Patch Production by Type (2020-2031)
4.2.3 Global Medicated Adhesive Patch Production Market Share by Type (2020-2031)
4.3 Global Medicated Adhesive Patch Production Value by Type
4.3.1 Global Medicated Adhesive Patch Production Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Medicated Adhesive Patch Production Value by Type (2020-2031)
4.3.3 Global Medicated Adhesive Patch Production Value Market Share by Type (2020-2031)
5 Medicated Adhesive Patch Market by Application
5.1 Medicated Adhesive Patch Application Introduction
5.1.1 Used to Treat High Blood Pressure
5.1.2 Used to Treat an Overactive Bladder
5.1.3 Used to Relieve Severe Pain
5.1.4 Used to Stop Smoking Cigarettes
5.1.5 Others
5.2 Global Medicated Adhesive Patch Production by Application
5.2.1 Global Medicated Adhesive Patch Production by Application (2020 VS 2024 VS 2031)
5.2.2 Global Medicated Adhesive Patch Production by Application (2020-2031)
5.2.3 Global Medicated Adhesive Patch Production Market Share by Application (2020-2031)
5.3 Global Medicated Adhesive Patch Production Value by Application
5.3.1 Global Medicated Adhesive Patch Production Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Medicated Adhesive Patch Production Value by Application (2020-2031)
5.3.3 Global Medicated Adhesive Patch Production Value Market Share by Application (2020-2031)
6 Company Profiles
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Comapny Information
6.1.2 Johnson & Johnson Business Overview
6.1.3 Johnson & Johnson Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Medicated Adhesive Patch Product Portfolio
6.1.5 Johnson & Johnson Recent Developments
6.2 Novartis
6.2.1 Novartis Comapny Information
6.2.2 Novartis Business Overview
6.2.3 Novartis Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.2.4 Novartis Medicated Adhesive Patch Product Portfolio
6.2.5 Novartis Recent Developments
6.3 Mylan
6.3.1 Mylan Comapny Information
6.3.2 Mylan Business Overview
6.3.3 Mylan Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.3.4 Mylan Medicated Adhesive Patch Product Portfolio
6.3.5 Mylan Recent Developments
6.4 Pfizer
6.4.1 Pfizer Comapny Information
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.4.4 Pfizer Medicated Adhesive Patch Product Portfolio
6.4.5 Pfizer Recent Developments
6.5 GSK
6.5.1 GSK Comapny Information
6.5.2 GSK Business Overview
6.5.3 GSK Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.5.4 GSK Medicated Adhesive Patch Product Portfolio
6.5.5 GSK Recent Developments
6.6 Beijing Tide Pharmaceutical
6.6.1 Beijing Tide Pharmaceutical Comapny Information
6.6.2 Beijing Tide Pharmaceutical Business Overview
6.6.3 Beijing Tide Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.6.4 Beijing Tide Pharmaceutical Medicated Adhesive Patch Product Portfolio
6.6.5 Beijing Tide Pharmaceutical Recent Developments
6.7 Bayer
6.7.1 Bayer Comapny Information
6.7.2 Bayer Business Overview
6.7.3 Bayer Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.7.4 Bayer Medicated Adhesive Patch Product Portfolio
6.7.5 Bayer Recent Developments
6.8 UCB Pharma
6.8.1 UCB Pharma Comapny Information
6.8.2 UCB Pharma Business Overview
6.8.3 UCB Pharma Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.8.4 UCB Pharma Medicated Adhesive Patch Product Portfolio
6.8.5 UCB Pharma Recent Developments
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Comapny Information
6.9.2 Teva Pharmaceutical Business Overview
6.9.3 Teva Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.9.4 Teva Pharmaceutical Medicated Adhesive Patch Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments
6.10 Nitto Denko
6.10.1 Nitto Denko Comapny Information
6.10.2 Nitto Denko Business Overview
6.10.3 Nitto Denko Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.10.4 Nitto Denko Medicated Adhesive Patch Product Portfolio
6.10.5 Nitto Denko Recent Developments
6.11 Mundipharma
6.11.1 Mundipharma Comapny Information
6.11.2 Mundipharma Business Overview
6.11.3 Mundipharma Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.11.4 Mundipharma Medicated Adhesive Patch Product Portfolio
6.11.5 Mundipharma Recent Developments
6.12 Luye Pharma Group
6.12.1 Luye Pharma Group Comapny Information
6.12.2 Luye Pharma Group Business Overview
6.12.3 Luye Pharma Group Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.12.4 Luye Pharma Group Medicated Adhesive Patch Product Portfolio
6.12.5 Luye Pharma Group Recent Developments
6.13 IBSA Group
6.13.1 IBSA Group Comapny Information
6.13.2 IBSA Group Business Overview
6.13.3 IBSA Group Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.13.4 IBSA Group Medicated Adhesive Patch Product Portfolio
6.13.5 IBSA Group Recent Developments
6.14 Hisamitsu Pharmaceutical
6.14.1 Hisamitsu Pharmaceutical Comapny Information
6.14.2 Hisamitsu Pharmaceutical Business Overview
6.14.3 Hisamitsu Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.14.4 Hisamitsu Pharmaceutical Medicated Adhesive Patch Product Portfolio
6.14.5 Hisamitsu Pharmaceutical Recent Developments
6.15 Grünenthal
6.15.1 Grünenthal Comapny Information
6.15.2 Grünenthal Business Overview
6.15.3 Grünenthal Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.15.4 Grünenthal Medicated Adhesive Patch Product Portfolio
6.15.5 Grünenthal Recent Developments
6.16 Endo International
6.16.1 Endo International Comapny Information
6.16.2 Endo International Business Overview
6.16.3 Endo International Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.16.4 Endo International Medicated Adhesive Patch Product Portfolio
6.16.5 Endo International Recent Developments
6.17 Dr Reddy’s Laboratories
6.17.1 Dr Reddy’s Laboratories Comapny Information
6.17.2 Dr Reddy’s Laboratories Business Overview
6.17.3 Dr Reddy’s Laboratories Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.17.4 Dr Reddy’s Laboratories Medicated Adhesive Patch Product Portfolio
6.17.5 Dr Reddy’s Laboratories Recent Developments
6.18 Chattem
6.18.1 Chattem Comapny Information
6.18.2 Chattem Business Overview
6.18.3 Chattem Medicated Adhesive Patch Production, Value and Gross Margin (2020-2025)
6.18.4 Chattem Medicated Adhesive Patch Product Portfolio
6.18.5 Chattem Recent Developments
7 Global Medicated Adhesive Patch Production by Region
7.1 Global Medicated Adhesive Patch Production by Region: 2020 VS 2024 VS 2031
7.2 Global Medicated Adhesive Patch Production by Region (2020-2031)
7.2.1 Global Medicated Adhesive Patch Production by Region: 2020-2025
7.2.2 Global Medicated Adhesive Patch Production Forecast by Region: 2026-2031
7.3 Global Medicated Adhesive Patch Production by Region: 2020 VS 2024 VS 2031
7.4 Global Medicated Adhesive Patch Production Value by Region (2020-2031)
7.4.1 Global Medicated Adhesive Patch Production Value by Region: 2020-2025
7.4.2 Global Medicated Adhesive Patch Production Value by Region (2026-2031)
7.5 Global Medicated Adhesive Patch Market Price Analysis by Region (2020-2031)
7.6 Regional Production Value Trends (2020-2031)
7.6.1 North America Medicated Adhesive Patch Production Value (2020-2031)
7.6.2 Europe Medicated Adhesive Patch Production Value (2020-2031)
7.6.3 Asia-Pacific Medicated Adhesive Patch Production Value (2020-2031)
7.6.4 South America Medicated Adhesive Patch Production Value (2020-2031)
7.6.5 Middle East & Africa Medicated Adhesive Patch Production Value (2020-2031)
8 Global Medicated Adhesive Patch Consumption by Region
8.1 Global Medicated Adhesive Patch Consumption by Region: 2020 VS 2024 VS 2031
8.2 Global Medicated Adhesive Patch Consumption by Region (2020-2031)
8.2.1 Global Medicated Adhesive Patch Consumption by Region (2020-2025)
8.2.2 Global Medicated Adhesive Patch Consumption by Region (2026-2031)
8.3 North America
8.3.1 North America Medicated Adhesive Patch Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.3.2 North America Medicated Adhesive Patch Consumption by Country (2020-2031)
8.3.3 U.S.
8.3.4 Canada
8.3.5 Mexico
8.4 Europe
8.4.1 Europe Medicated Adhesive Patch Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.4.2 Europe Medicated Adhesive Patch Consumption by Country (2020-2031)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Netherlands
8.5 Asia Pacific
8.5.1 Asia Pacific Medicated Adhesive Patch Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.5.2 Asia Pacific Medicated Adhesive Patch Consumption by Country (2020-2031)
8.5.3 China
8.5.4 Japan
8.5.5 South Korea
8.5.6 Southeast Asia
8.5.7 India
8.5.8 Australia
8.6 South America
8.6.1 South America Medicated Adhesive Patch Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.6.2 South America Medicated Adhesive Patch Consumption by Country (2020-2031)
8.6.3 Brazil
8.6.4 Argentina
8.6.5 Chile
8.6.6 Colombia
8.7 Middle East & Africa
8.7.1 Middle East & Africa Medicated Adhesive Patch Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.7.2 Middle East & Africa Medicated Adhesive Patch Consumption by Country (2020-2031)
8.7.3 Egypt
8.7.4 South Africa
8.7.5 Israel
8.7.6 Türkiye
8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
9.1 Medicated Adhesive Patch Value Chain Analysis
9.1.1 Medicated Adhesive Patch Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Medicated Adhesive Patch Production Mode & Process
9.2 Medicated Adhesive Patch Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Medicated Adhesive Patch Distributors
9.2.3 Medicated Adhesive Patch Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.